The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort

Author:

Ayanian Shant1ORCID,Reyes Juan1ORCID,Lynn Lei1ORCID,Teufel Karolyn1ORCID

Affiliation:

1. The George Washington University School of Medicine & Health Sciences, Division of Hospital Medicine, The GW Medical Faculty Associates, DC 20037, USA

Abstract

Aim: To describe the association between D-dimer, CRP, IL-6, ferritin, LDH and the clinical outcomes in a cohort of 299 COVID-19 patients treated on the inpatient medical service at a university hospital in the District of Columbia (DC, USA). Methodology & results: In this retrospective study, we included all laboratory confirmed COVID-19 adults admitted to the inpatient medicine service at the George Washington University Hospital between 12 March 2020 and 9 May 2020. We analyzed the association of biomarkers on intensive care unit transfer, intubation and mortality. Threshold values for all biomarkers were found to be statistically significant and independently associated with higher odds of clinical deterioration and death. Conclusion: Laboratory markers of inflammation and coagulopathy can help clinicians identify patients who are at high risk for clinical deterioration in COVID-19.

Publisher

Future Medicine Ltd

Subject

Biochemistry (medical),Clinical Biochemistry,Drug Discovery

Reference16 articles.

1. The World Health Organization (who.int). Coronavirus disease (COVID-19) - Events As They Happen. (2020). www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen

2. McNamara A. CDC Confirms First Case of Coronavirus in United States. (2020). www.cbsnews.com/news/coronavirus-centers-for-disease-control-first-case-united-states/

3. Selsky A. Washington governor declares state of emergency over virus. (2020). https://apnews.com/f175d89567a26d59cab27725c9e8a0d7

4. Custis A. A timeline of the DC region's COVID pandemic. ( 2020). www.dcpolicycenter.org/publications/covid-19-timeline/

5. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3